A nurse is preparing to administer enoxaparin 5 mg/kg subcutaneous daily to a client who has deep-vein thrombosis. The client weighs 152 lb. Available is 120 mg/0.8 mL prefilled syringe. Calculate the dosage in mL that the nurse should administer. (Round the answer to the nearest tenth. Use a leading zero if applicable. Do not use a trailing zero.)
The Correct Answer is ["2.3"]
1 lb = 0.453592 kg (conversion factor)
Weight in kilograms = 152 lb × 0.453592 kg/lb ≈ 68.946 kg
Calculate the total dosage based on the client's weight:
Total dosage = 5 mg/kg × 68.946 kg
≈ 344.73mg
Determine the volume of enoxaparin solution needed based on the concentration provided: Available concentration: 120 mg/0.8 mL
Dosage required: 344.73 mg Using the formula:
Volume (mL) = Dosage required (mg) / Concentration (mg/mL)
= 344.73mg / 120 mg/0.8 mL
= 2.3ml
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
D. Chills are a hallmark sign of febrile nonhemolytic reactions. These reactions typically present with fever, chills, and occasionally rigors (shivering). They are caused by recipient antibodies reacting to donor leukocytes or cytokines present in the transfused blood components.
A. Dyspnea (difficulty breathing) is not typically associated with febrile nonhemolytic reactions. It is more commonly seen in acute hemolytic reactions or transfusion-related acute lung injury (TRALI).
B. Urticaria (hives) is more commonly associated with allergic transfusion reactions rather than febrile nonhemolytic reactions.
C. Vomiting is not a characteristic feature of febrile nonhemolytic reactions. It may occur in some cases of transfusion reactions, but it is not specific to febrile nonhemolytic reactions.
Correct Answer is B
Explanation
B. Maculopapular rash is a potential adverse effect of ceftriaxone. It is a type of skin rash characterized by flat, red areas (macules) and raised, bumpy areas (papules). If a client develops a rash while taking ceftriaxone, it should be reported to the healthcare provider for evaluation.
A. Constipation is not a common adverse effect of ceftriaxone. It is more commonly associated with other medications or medical conditions unrelated to ceftriaxone.
C. Pitting edema is not a common adverse effect of ceftriaxone. It may occur as a result of other medical conditions or medications, but it is not specifically associated with ceftriaxone.
D. Concentrated urine is not a common adverse effect of ceftriaxone.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today